InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,708.75
(
-0.93%
)
US TECH 100
19,229.60
(
-0.11%
)
Dow Jones
42,156.97
(
-0.41%
)
Brent Oil
75.78
(
1.83%
)
Bitcoin
61,206.86
(
0.62%
)
Post# of 253265
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Superfly15

Send PM Follow Ignore
Followers 36
Posts 2600
Boards Moderated 0
Alias Born 03/23/2010

Superfly15

Re: DewDiligence post# 139249

Monday, 03/26/2012 10:55:54 PM

Monday, March 26, 2012 10:55:54 PM

Post# of 253265
Have to hand it to Gekkowire on that one, he was WAY ahead of the game seeing it.

I think these guys are hiding something...they did a usability study in spring 2011. They know exactly what's going on, and IMO if they resubmit there is another CRL + trial or inhaler design change coming. Smells just like MNKD.


Usability study 5/3/11 NDA submission 5/26/11

http://www.mappharma.com/file.cfm/124/docs/MAP019_RDD_Web2.pdf
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up